NEW: Premarket Now Starts at 4AM!

We’re excited to announce the extension of premarket and aftermarket hours! Our members now have access to quotes daily from 4:00 AM to 8:00 PM ET — offering greater flexibility and deeper insights into market trends beyond regular trading hours.

Upgrade to FINVIZ*Elite to access premarket quotes »

HRMY

Harmony Biosciences Holdings Inc

Apr 23 • 04:00PM ET

28.90

Dollar change -0.28
Percentage change -0.96	%

Healthcare • Biotechnology • USA • NASD

Peers: MRK LLY PFE JNJ AMGN VRTX REGN GILD BIIB NBIX

| Held by: IJR VTI VB AVUV IWM VBK VXF CALF IJT IWO

Scroll to Statements

Index	RUT	P/E	11.51	EPS (ttm)	2.51	Insider Own	24.13%	Shs Outstand	57.14M	Perf Week	0.52%
Market Cap	1.66B	Forward P/E	7.14	EPS next Y	4.05	Insider Trans	-40.29%	Shs Float	43.54M	Perf Month	-15.60%
Income	145.49M	PEG	0.41	EPS next Q	0.63	Inst Own	83.47%	Short Float	8.02%	Perf Quarter	-25.25%
Sales	714.73M	P/S	2.32	EPS this Y	25.13%	Inst Trans	6.01%	Short Ratio	4.98	Perf Half Y	-18.38%
Book/sh	11.53	P/B	2.51	EPS next Y	28.86%	ROA	16.07%	Short Interest	3.49M	Perf Year	-1.70%
Cash/sh	8.14	P/C	3.55	EPS next 5Y	27.84%	ROE	25.84%	52W Range	26.47 - 41.61	Perf YTD	-16.01%
Dividend Est.	-	P/FCF	7.58	EPS past 5Y	-	ROI	17.68%	52W High	-30.55%	Beta	0.84
Dividend TTM	-	Quick Ratio	3.27	Sales past 5Y	550.98%	Gross Margin	74.72%	52W Low	9.18%	ATR (14)	1.40
Dividend Ex-Date	-	Current Ratio	3.31	EPS Y/Y TTM	18.12%	Oper. Margin	26.70%	RSI (14)	38.06	Volatility	3.66% 4.67%
Employees	268	Debt/Eq	0.35	Sales Y/Y TTM	22.80%	Profit Margin	20.36%	Recom	1.33	Target Price	51.78
Option/Short	Yes / Yes	LT Debt/Eq	0.25	EPS Q/Q	87.97%	Payout	0.00%	Rel Volume	0.91	Prev Close	29.18
Sales Surprise	0.14%	EPS Surprise	15.80%	Sales Q/Q	19.51%	Earnings	Feb 25 BMO	Avg Volume	701.97K	Price	28.90
SMA20	-4.17%	SMA50	-12.20%	SMA200	-16.78%	Trades		Volume	662,203	Change	-0.96%

Date	Action	Analyst	Rating Change	Price Target Change
Feb-11-25	Initiated	Deutsche Bank	Buy	$55
Dec-17-24	Initiated	H.C. Wainwright	Buy	$75
Oct-10-24	Resumed	Raymond James	Outperform
Sep-10-24	Initiated	UBS	Buy	$56
Jun-21-24	Initiated	Citigroup	Buy	$48
Jan-02-24	Downgrade	BofA Securities	Neutral → Underperform	$30
Sep-25-23	Downgrade	Goldman	Neutral → Sell	$40 → $31
Sep-07-23	Initiated	Berenberg	Buy	$59
Apr-20-23	Initiated	BofA Securities	Neutral	$35
Oct-14-22	Upgrade	Jefferies	Hold → Buy	$57 → $61
Oct-14-22	Upgrade	Janney	Neutral → Buy	$57 → $61
Aug-03-22	Downgrade	Jefferies	Buy → Hold	$57
Jul-13-22	Downgrade	Goldman	Buy → Neutral	$55
Jul-07-22	Initiated	Mizuho	Buy	$64
Apr-14-22	Initiated	Cantor Fitzgerald	Overweight	$63
Dec-01-21	Initiated	Oppenheimer	Outperform	$55
Nov-04-21	Initiated	Raymond James	Outperform	$58
Sep-23-21	Initiated	Needham	Buy	$57
Mar-29-21	Upgrade	Goldman	Neutral → Buy	$41 → $43
Sep-14-20	Initiated	Piper Sandler	Overweight	$61

Show Previous Ratings

Apr-21-25 07:36AM	JAZZ vs. HRMY: Which Neuroscience Drugmaker Is the Stronger Play? (Zacks)
Apr-16-25 02:41PM	IYH: Healthcare Dashboard For April (Seeking Alpha)
Apr-08-25 08:05AM	Harmony Biosciences Presents Promising Open-Label Extension Data of ZYN002 in Fragile X Syndrome (Business Wire)
Apr-04-25 09:17AM	Harmony Biosciences Holdings, Inc. (HRMY): A Bull Case Theory (Insider Monkey) -5.52%
Apr-03-25 08:05AM	Harmony Biosciences Appoints Biotech Leader Ron Philip to Its Board of Directors (Business Wire)
11:23PM	Loading…
Mar-26-25 11:23PM	Is Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) the Best Small Cap Stock to Buy Before They Explode? (InsiderMonkey)
08:05AM	Harmony Biosciences to Participate in 24th Annual Needham Virtual Healthcare Conference (Business Wire)
Mar-24-25 12:09PM	Harmony Biosciences: A Compelling Risk-Reward Opportunity (SeekingAlpha)
08:05AM	Harmony Biosciences Names Adam Zaeske as Chief Commercial Officer to Lead the Next Phase of Commercial Growth as Its Portfolio Expands (Business Wire)
Mar-19-25 12:14PM	HRMY Down 10.8% in Six Months: How Should You Play the Stock? (Zacks)
Mar-07-25 03:36AM	Harmony Biosciences Holdings, Inc. (HRMY): Among the Cash-Rich Small Cap Stocks To Invest In According To Analysts (Insider Monkey)
Mar-04-25 08:05AM	Harmony Biosciences to Participate in Upcoming Investor Conferences (Business Wire)
Feb-26-25 09:40AM	Should Value Investors Buy Harmony Biosciences (HRMY) Stock? (Zacks) -9.47%
03:39AM	Q4 2024 Harmony Biosciences Holdings Inc Earnings Call (Thomson Reuters StreetEvents)
02:06AM	Harmony Biosciences Holdings Inc (HRMY) Q4 2024 Earnings Call Highlights: Strong Revenue Growth ... (GuruFocus.com)
02:15PM	Loading…
Feb-25-25 02:15PM	Harmony Biosciences (HRMY) Q4 2024 Earnings Call Transcript (Motley Fool) +8.16%
12:31PM	Is Harmony Biosciences Holdings, Inc. (HRMY) the Best Small-Cap Growth Stock to Buy Now? (Insider Monkey)
08:50AM	Harmony Biosciences Holdings, Inc. (HRMY) Tops Q4 Earnings and Revenue Estimates (Zacks)
07:30AM	Harmony Biosciences Reports Strong 2024 Financial Results and Reiterates 2025 Net Revenue Guidance; Highlights 2025 Catalysts in Sleep/Wake and Fragile X Syndrome Development Programs (Business Wire)
01:30AM	Earnings To Watch: Harmony Biosciences Holdings Inc (HRMY) Reports Q4 2024 Result (GuruFocus.com)
Feb-24-25 01:04PM	Is Harmony Biosciences (HRMY) the Oversold Biotech Stock to Buy Now? (Insider Monkey)
12:00PM	Harmony Biosciences (HRMY) Upgraded to Strong Buy: Here's Why (Zacks)
Feb-19-25 04:39PM	Harmony Biosciences Crashes On Surprise Rejection For Bread-And-Butter Drug (Investor's Business Daily) -9.64%
02:24PM	Harmony Biosciences Stock Falls On FDA Setback For Pitolisant In Sleeping Disorder (Benzinga)
08:05AM	Harmony Biosciences Provides Update on the Status of the Supplemental New Drug Application for Pitolisant in Idiopathic Hypersomnia (Business Wire)
Feb-18-25 08:05AM	Harmony Biosciences to Report Fourth Quarter and Full Year 2024 Financial Results on February 25, 2025 (Business Wire)
Feb-13-25 12:45PM	Here is Why Growth Investors Should Buy Harmony Biosciences (HRMY) Now (Zacks)
Feb-12-25 06:17AM	Harmony Biosciences Holdings, Inc (HRMY): A Cheap Biotech Stock to Invest In Now (Insider Monkey)
Feb-05-25 09:40AM	Are Investors Undervaluing Harmony Biosciences (HRMY) Right Now? (Zacks)
Jan-31-25 09:55AM	Wall Street Analysts Predict a 28.98% Upside in Harmony Biosciences (HRMY): Here's What You Should Know (Zacks)
03:32PM	Loading…
Jan-30-25 03:32PM	Harmony Biosciences Stock Scores 80-Plus RS Rating (Investor's Business Daily)
Jan-20-25 09:40AM	Should Value Investors Buy Harmony Biosciences (HRMY) Stock? (Zacks)
Jan-15-25 12:20PM	Why Harmony Biosciences (HRMY) Might be Well Poised for a Surge (Zacks)
09:55AM	How Much Upside is Left in Harmony Biosciences (HRMY)? Wall Street Analysts Think 39.48% (Zacks)
08:11AM	Harmony Biosciences price target raised to $32 from $31 at BofA (TipRanks)
Jan-13-25 04:15PM	Why Harmony Biosciences (HRMY) Is the Top Small Cap Stock to Buy with the Highest Upside Potential (Insider Monkey) +7.65%
04:15PM	BridgeBio, ARS Pharma, Harmony Bio Shine At JPM. But SpringWorks, Beam Take Their Lumps. (Investor's Business Daily)
08:05AM	Harmony Biosciences Reports Strong 2024 Revenues, Provides 2025 Revenue Guidance and Highlights Key Pipeline Catalysts (Business Wire)
Dec-18-24 08:05AM	HARMONY BIOSCIENCES TO PRESENT AT THE 43RD ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE (PR Newswire)
Dec-03-24 08:05AM	HARMONY BIOSCIENCES TO PARTICIPATE IN OPPENHEIMER MOVERS IN RARE DISEASE SUMMIT (PR Newswire)
Nov-21-24 08:05AM	HARMONY BIOSCIENCES TO PARTICIPATE IN UPCOMING INVESTOR CONFERENCES (PR Newswire)
Nov-01-24 09:40AM	Are Investors Undervaluing Harmony Biosciences (HRMY) Right Now? (Zacks)
Oct-30-24 10:30PM	Harmony Biosciences Holdings, Inc. Announces Pricing of Public Offering of Common Stock by Selling Shareholders (PR Newswire) -18.53%
06:00AM	Axonis Therapeutics Announces $115 Million Series A Financing (PR Newswire)
03:06AM	Harmony Biosciences Holdings Inc (HRMY) Q3 2024 Earnings Call Highlights: Strong Revenue Growth ... (GuruFocus.com)
02:26AM	Q3 2024 Harmony Biosciences Holdings Inc Earnings Call (Thomson Reuters StreetEvents)
Oct-29-24 05:15PM	Harmony Biosciences Holdings, Inc. Announces Commencement of Proposed Public Offering of Common Stock by Selling Shareholders (PR Newswire) +16.06%
04:12PM	Harmony Bio, The No. 1 Biotech Stock, Surges On Its 'High Quality' Beat (Investor's Business Daily)
04:00PM	Harmony Biosciences (HRMY) Q3 2024 Earnings Call Transcript (Motley Fool)
08:40AM	Harmony Biosciences Holdings, Inc. (HRMY) Q3 Earnings and Revenues Surpass Estimates (Zacks)
07:30AM	HARMONY BIOSCIENCES REPORTS STRONG THIRD QUARTER 2024 FINANCIAL RESULTS AND HIGHLIGHTS CATALYST-RICH, LATE-STAGE PIPELINE POISED TO DELIVER ONE OR MORE NEW LAUNCHES EVERY YEAR OVER NEXT FIVE YEARS (PR Newswire)
Oct-22-24 10:01AM	Harmony Biosciences Holdings, Inc. (HRMY) Earnings Expected to Grow: Should You Buy? (Zacks)
Oct-16-24 08:05AM	HARMONY BIOSCIENCES TO REPORT THIRD QUARTER 2024 FINANCIAL RESULTS ON OCTOBER 29, 2024 (PR Newswire)
Oct-14-24 09:51AM	Wall Street Analysts Favor Harmony Biosciences Holdings, Inc. (HRMY) for Growth (Insider Monkey)
Oct-11-24 12:14PM	Is Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) The Top Stock With Improving Technical Ratings According To Piper Sandler? (Insider Monkey)
Oct-09-24 05:02PM	Harmony Biosciences Holdings Inc (HRMY) Q2 2024 Earnings Call Highlights: Strong Revenue Growth ... (GuruFocus.com)
Oct-03-24 11:11AM	Mizuho adds 2 new stocks to its Top Picks list (Investing.com)
Oct-01-24 08:45AM	HARMONY BIOSCIENCES HIGHLIGHTS NEW DATA, ROBUST LATE-STAGE PIPELINE WITH NEAR-TERM VALUE CREATION OPPORTUNITIES AND ITS BOLD NEW VISION AT INVESTOR DAY (PR Newswire)
Sep-29-24 04:43AM	Is Harmony Biosciences Holdings, Inc. (HRMY) the Best Cheap Growth Stock to Buy According to Analysts? (Insider Monkey)
Sep-27-24 05:23AM	Harmony Biosciences (HRMY) Surges 6.7%: Is This an Indication of Further Gains? (Zacks)
Sep-26-24 08:05AM	HARMONY BIOSCIENCES TO HOST FIRST INVESTOR DAY ON OCTOBER 1, 2024 (PR Newswire) +6.70%
Sep-25-24 09:40AM	Is Harmony Biosciences (HRMY) Stock Undervalued Right Now? (Zacks)
Sep-24-24 12:00PM	Harmony Biosciences (HRMY) Upgraded to Buy: Here's What You Should Know (Zacks)
Sep-21-24 02:26AM	Harmony Biosciences Holdings, Inc. (HRMY): Short Seller Sentiment is Bearish (Insider Monkey)
Sep-10-24 02:56PM	Neurology-Focused Harmony Biosciences Gains Confidence With Wakix Sales Surge, Strategic Pipeline Expansion, Bullish Analyst Says (Benzinga)
Aug-26-24 09:40AM	Is Harmony Biosciences (HRMY) a Great Value Stock Right Now? (Zacks)
Aug-21-24 08:05AM	HARMONY BIOSCIENCES TO PARTICIPATE IN UPCOMING INVESTOR CONFERENCES (PR Newswire)
Aug-16-24 12:20PM	Surging Earnings Estimates Signal Upside for Harmony Biosciences (HRMY) Stock (Zacks)
Aug-14-24 09:55AM	Can Harmony Biosciences (HRMY) Climb 25.05% to Reach the Level Wall Street Analysts Expect? (Zacks)
Aug-09-24 09:40AM	Should Value Investors Buy Harmony Biosciences (HRMY) Stock? (Zacks)
Aug-06-24 09:15PM	Harmony Biosciences (HRMY) Q2 2024 Earnings Call Transcript (Motley Fool) +6.18%
08:45AM	Harmony Biosciences Holdings, Inc. (HRMY) Surpasses Q2 Earnings and Revenue Estimates (Zacks)
07:30AM	Harmony Biosciences Reports Strong Second Quarter 2024 Financial Results and Advances Pitolisant High-Dose Program Toward Expected PDUFA Date in 2028 (GlobeNewswire)
Jul-23-24 08:05AM	HARMONY BIOSCIENCES TO REPORT SECOND QUARTER 2024 FINANCIAL RESULTS ON AUGUST 6, 2024 (PR Newswire)
Jul-19-24 09:55AM	Wall Street Analysts See a 32.82% Upside in Harmony Biosciences (HRMY): Can the Stock Really Move This High? (Zacks)
Jul-17-24 09:50AM	Are Investors Undervaluing Harmony Biosciences (HRMY) Right Now? (Zacks)
Jul-09-24 06:00AM	7 Cheap Biotech Stocks With Major Upside Potential (InvestorPlace) +6.24%
Jul-01-24 02:18PM	7 Undervalued Biotech Stocks to Buy for Big-Time Returns (InvestorPlace)
Jun-25-24 08:05AM	HARMONY BIOSCIENCES ACKNOWLEDGES U.S. FOOD & DRUG ADMINISTRATION (FDA) ACTION DENYING THE CITIZEN PETITION FOR WAKIX® (PITOLSIANT) (PR Newswire)
08:05AM	HARMONY BIOSCIENCES ACKNOWLEDGES U.S. FOOD & DRUG ADMINISTRATION (FDA) ACTION DENYING THE CITIZEN PETITION FOR WAKIX (PITOLISANT) (PR Newswire)
Jun-24-24 12:56PM	7 Biotech Stocks to Buy on the Dip: June 2024 (InvestorPlace)
07:00AM	HARMONY BIOSCIENCES RECEIVES U.S. FOOD AND DRUG ADMINISTRATION APPROVAL FOR WAKIX (PITOLISANT) IN PEDIATRIC PATIENTS WITH NARCOLEPSY (PR Newswire)
Jun-05-24 08:05AM	HARMONY BIOSCIENCES PRESENTS POSITIVE DATA FOR PITOLISANT IN THE TREATMENT OF EXCESSIVE DAYTIME SLEEPINESS AND FATIGUE IN MYOTONIC DYSTROPHY TYPE 1 (PR Newswire)
May-28-24 08:05AM	HARMONY BIOSCIENCES TO PARTICIPATE IN GOLDMAN SACHS 45th ANNUAL GLOBAL HEALTHCARE CONFERENCE (PR Newswire)
May-01-24 12:45PM	Looking for a Growth Stock? 3 Reasons Why Harmony Biosciences (HRMY) is a Solid Choice (Zacks)
11:07AM	Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Q1 2024 Earnings Call Transcript (Insider Monkey)
Apr-30-24 05:45PM	Harmony Biosciences (HRMY) Q1 2024 Earnings Call Transcript (Motley Fool) +5.68%
01:44PM	Harmony Biosciences Expands It CNS-Focused Pipeline With Epilepsy Candidate, Q1 Earnings Beat Street View (Benzinga)
11:54AM	HRMY Stock Earnings: Harmony Biosciences Beats EPS, Misses Revenue for Q1 2024 (InvestorPlace)
10:54AM	Harmony Biosciences Acquires Epygenix Therapeutics; Shares Rise (MT Newswires)
09:12AM	Harmony Biosciences Exceeds Analyst Revenue Forecasts While Aligning with EPS Projections in Q1 2024 (GuruFocus.com)
07:05AM	Harmony Biosciences Reports Strong First Quarter Financial Results and Acceleration of Its Growth Strategy; Advances Pitolisant Franchise to Extend Revenue Potential Beyond 2040; Strenghtens Sleep/Wake Leadership and Diversifies Into Rare Epilepsy (GlobeNewswire)
07:00AM	Harmony Biosciences Acquires Epygenix Therapeutics, Inc., Adding Late-Stage Epilepsy Franchise to Growing Pipeline of Innovative CNS Assets (PR Newswire)
Apr-16-24 08:05AM	HARMONY BIOSCIENCES TO REPORT FIRST QUARTER 2024 FINANCIAL RESULTS ON APRIL 30, 2024 (PR Newswire)
Apr-11-24 08:05AM	HARMONY BIOSCIENCES ANNOUNCES EXCLUSIVE AGREEMENT TO DEVELOP AND COMMERCIALIZE TPM-1116, A HIGHLY POTENT AND SELECTIVE ORAL OREXIN-2 RECEPTOR AGONIST (PR Newswire) +6.44%
Apr-03-24 08:05AM	HARMONY BIOSCIENCES INITIATES GLOBAL PHASE 3 REGISTRATIONAL TRIAL (TEMPO STUDY) OF PITOLISANT IN PATIENTS WITH PRADER-WILLI SYNDROME (PR Newswire)
Mar-26-24 08:05AM	HARMONY BIOSCIENCES TO PARTICIPATE IN 23RD ANNUAL NEEDHAM VIRTUAL HEALTHCARE CONFERENCE (PR Newswire)
Mar-19-24 01:26AM	Harmony Biosciences Holdings Inc's Chief Commercial Officer Sells Company Shares (GuruFocus.com)
Mar-08-24 09:38AM	10 Biotech Stocks with Huge Potential (Insider Monkey)
Feb-28-24 08:05AM	HARMONY BIOSCIENCES TO PARTICIPATE IN UPCOMING INVESTOR CONFERENCES (PR Newswire)

Harmony Biosciences Holdings, Inc. is a commercial-stage pharmaceutical company, which engages in the provision of development and commercialization of therapies for the treatment of neurological disorders. Its product, WAKIX, is a molecule with a novel mechanism of action designed to increase histamine signaling in the brain by binding to H3 receptors. The company was founded by Jeffrey S. Aronin on July 25, 2017 and is headquartered in Plymouth Meeting, PA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Kapadia Sandip	CHIEF FINANCIAL OFFICER	Apr 01 '25	Sale	32.54	6,987	227,386	0	Apr 03 04:15 PM
SANDIP KAPADIA	Officer	Apr 01 '25	Proposed Sale	33.19	6,986	231,865		Apr 01 04:27 PM
Kapadia Sandip	CHIEF FINANCIAL OFFICER	Mar 29 '25	Option Exercise	0.00	15,000	0	15,000	Apr 01 04:10 PM
Dierks Jeffrey	CHIEF COMMERCIAL OFFICER	Mar 03 '25	Option Exercise	8.22	4,869	40,023	4,869	Mar 05 04:05 PM
Dierks Jeffrey	CHIEF COMMERCIAL OFFICER	Mar 03 '25	Sale	32.67	4,869	159,090	0	Mar 05 04:05 PM
JEFFREY G DIERKS	Officer	Mar 03 '25	Proposed Sale	33.85	4,869	164,816		Mar 03 04:15 PM
Budur Kumar	CHIEF MEDICAL OFFICER	Jan 24 '25	Option Exercise	0.00	2,187	0	2,187	Jan 28 04:10 PM
Dierks Jeffrey	CHIEF COMMERCIAL OFFICER	Jan 24 '25	Option Exercise	25.47	15,812	402,806	13,125	Jan 28 04:08 PM
Dierks Jeffrey	CHIEF COMMERCIAL OFFICER	Jan 24 '25	Sale	37.31	13,125	489,634	0	Jan 28 04:08 PM
Dierks Jeffrey	CHIEF COMMERCIAL OFFICER	Jan 27 '25	Sale	38.02	1,629	61,941	0	Jan 28 04:08 PM
Dayno Jeffrey M.	PRESIDENT, CEO	Jan 24 '25	Option Exercise	0.00	10,500	0	10,500	Jan 28 04:07 PM
Kapadia Sandip	CHIEF FINANCIAL OFFICER	Jan 24 '25	Option Exercise	0.00	3,812	0	3,812	Jan 28 04:04 PM
Kapadia Sandip	CHIEF FINANCIAL OFFICER	Jan 27 '25	Sale	38.05	1,775	67,547	0	Jan 28 04:04 PM
Serafin Andrew	CHIEF STRATEGY OFFICER	Jan 24 '25	Option Exercise	0.00	2,500	0	2,500	Jan 28 12:51 PM
JEFFREY G DIERKS	Officer	Jan 27 '25	Proposed Sale	38.01	1,629	61,918		Jan 27 04:27 PM
SANDIP KAPADIA	Officer	Jan 27 '25	Proposed Sale	38.01	1,775	67,468		Jan 27 04:27 PM
JEFFREY G DIERKS	Officer	Jan 24 '25	Proposed Sale	38.01	13,125	498,881		Jan 24 04:18 PM
Dayno Jeffrey M.	PRESIDENT, CEO	Jan 21 '25	Option Exercise	8.22	19,293	158,588	19,293	Jan 23 04:17 PM
Dayno Jeffrey M.	PRESIDENT, CEO	Jan 21 '25	Sale	40.13	19,293	774,245	0	Jan 23 04:17 PM
Kapadia Sandip	CHIEF FINANCIAL OFFICER	Jan 21 '25	Option Exercise	29.03	25,000	725,750	25,000	Jan 23 04:15 PM
Kapadia Sandip	CHIEF FINANCIAL OFFICER	Jan 21 '25	Sale	40.18	25,000	1,004,598	0	Jan 23 04:15 PM
Dierks Jeffrey	CHIEF COMMERCIAL OFFICER	Jan 16 '25	Option Exercise	33.44	29,475	985,644	29,475	Jan 21 08:44 PM
Dierks Jeffrey	CHIEF COMMERCIAL OFFICER	Jan 21 '25	Option Exercise	33.44	1,123	37,553	1,123	Jan 21 08:44 PM
Dierks Jeffrey	CHIEF COMMERCIAL OFFICER	Jan 16 '25	Sale	37.41	29,475	1,102,795	0	Jan 21 08:44 PM
Dierks Jeffrey	CHIEF COMMERCIAL OFFICER	Jan 21 '25	Sale	40.00	1,123	44,920	0	Jan 21 08:44 PM
SANDIP KAPADIA	Officer	Jan 21 '25	Proposed Sale	39.05	25,000	976,250		Jan 21 04:21 PM
JEFFREY M DAYNO	Director	Jan 21 '25	Proposed Sale	39.05	19,293	753,392		Jan 21 04:21 PM
JEFFREY G DIERKS	Officer	Jan 21 '25	Proposed Sale	39.05	1,123	43,853		Jan 21 04:20 PM
Dierks Jeffrey	CHIEF COMMERCIAL OFFICER	Jan 15 '25	Option Exercise	33.44	10,507	351,354	10,507	Jan 16 04:30 PM
Dierks Jeffrey	CHIEF COMMERCIAL OFFICER	Jan 15 '25	Sale	37.01	10,507	388,841	0	Jan 16 04:30 PM
Dierks Jeffrey	CHIEF COMMERCIAL OFFICER	Jan 13 '25	Option Exercise	33.44	7,180	240,099	7,180	Jan 15 04:30 PM
Dierks Jeffrey	CHIEF COMMERCIAL OFFICER	Jan 13 '25	Sale	37.04	7,180	265,946	0	Jan 15 04:30 PM
JEFFREY G DIERKS	Officer	Jan 13 '25	Proposed Sale	33.86	47,162	1,596,905		Jan 13 04:26 PM
Valor IV Pharma Holdings, LLC	10% Owner	Nov 01 '24	Sale	30.30	4,000,000	121,210,000	7,218,033	Nov 05 05:48 PM
Valor IV Pharma Holdings, LLC	10% Owner	Nov 05 '24	Sale	30.30	600,000	18,181,500	6,618,033	Nov 05 05:48 PM
Marshman Fund Trust II	10% Owner	Nov 01 '24	Sale	30.30	4,000,000	121,210,000	6,651,120	Nov 05 04:05 PM
Marshman Fund Trust II	10% Owner	Nov 05 '24	Sale	30.30	600,000	18,181,500	6,051,120	Nov 05 04:05 PM
Dierks Jeffrey	CHIEF COMMERCIAL OFFICER	Oct 29 '24	Option Exercise	24.00	21,496	515,904	21,496	Oct 31 04:45 PM
Dierks Jeffrey	CHIEF COMMERCIAL OFFICER	Oct 29 '24	Sale	40.47	21,496	870,018	0	Oct 31 04:45 PM
JEFFREY G DIERKS	Officer	Oct 29 '24	Proposed Sale	35.75	21,496	768,482		Oct 29 04:22 PM
JEFFREY G DIERKS	Officer	Oct 03 '24	Proposed Sale	35.57	14,961	532,163		Oct 03 04:32 PM
Dierks Jeffrey	CHIEF COMMERCIAL OFFICER	Oct 01 '24	Option Exercise	24.00	400	9,600	400	Oct 02 04:06 PM
Dierks Jeffrey	CHIEF COMMERCIAL OFFICER	Oct 01 '24	Sale	40.19	400	16,077	0	Oct 02 04:06 PM
Dierks Jeffrey	CHIEF COMMERCIAL OFFICER	Sep 30 '24	Option Exercise	0.00	60,000	0	60,000	Oct 02 04:05 PM
Kapadia Sandip	CHIEF FINANCIAL OFFICER	Sep 30 '24	Option Exercise	0.00	60,000	0	60,000	Oct 02 04:04 PM
JEFFREY G DIERKS	Officer	Oct 01 '24	Proposed Sale	40.00	21,796	871,840		Oct 01 04:35 PM
Dierks Jeffrey	CHIEF COMMERCIAL OFFICER	Sep 30 '24	Option Exercise	24.00	35,846	860,304	35,846	Oct 01 04:07 PM
Dierks Jeffrey	CHIEF COMMERCIAL OFFICER	Sep 30 '24	Sale	40.03	35,846	1,434,951	0	Oct 01 04:07 PM
JEFFREY G DIERKS	Officer	Sep 30 '24	Proposed Sale	39.13	7,175	280,758		Sep 30 04:28 PM
Dierks Jeffrey	CHIEF COMMERCIAL OFFICER	Sep 27 '24	Option Exercise	24.00	200	4,800	200	Sep 30 04:03 PM
Dierks Jeffrey	CHIEF COMMERCIAL OFFICER	Sep 27 '24	Sale	40.05	200	8,009	0	Sep 30 04:03 PM
JEFFREY G DIERKS	Officer	Sep 27 '24	Proposed Sale	39.79	28,971	1,152,756		Sep 27 04:24 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

HRMY

Harmony Biosciences Holdings Inc

Upgrade your FINVIZ experience